Belite Bio (BLTE) Non Operating Income (2022 - 2026)

Belite Bio's Non Operating Income history runs 5 years deep, the most recent figure standing at $5.7 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 363.39% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.4 billion (up 57.9% YoY), while the FY2025 annual figure was $6.6 million, up 71.0% from the prior year.
• Non Operating Income for Q1 2026 stood at $5.7 million, down from $2.8 billion in the prior quarter.
• The five-year high for Non Operating Income was $2.8 billion in Q4 2025, with the low at -$8.0 million in Q1 2023.
• The 5-year median for Non Operating Income is $126.0 million (2022), against an average of $595.5 million.
• The sharpest annual moves came in 2023 and 2024: Non Operating Income tumbled 99.98% in 2023, then soared 3929529.63% in 2024.
• Belite Bio's Non Operating Income stood at -$62000.0 in 2022, then jumped by 41.94% to -$36000.0 in 2023, then soared by 3769544.44% to $1.4 billion in 2024, then surged by 102.87% to $2.8 billion in 2025, then sank by 99.79% to $5.7 million in 2026.
• Business Quant data shows BLTE's Non Operating Income at $5.7 million in Q1 2026, $2.8 billion in Q4 2025, and $1.3 billion in Q3 2025.